The β-blocker DL-1-(2-nitro-3-methylphenoxy)-3-tert-butylaminopropan-2-ol (ZAMI 1305), hepatocarcinogenic to the female rat, and the non-oncogenic β-blockers DL-1-(2-nitro-5-methylphenoxy)-3-tert-butylaminopropan-2-ol (ZAMI 1327), DL-propranolol, and DL-atenolol were studied for their capacity to interfere with hepatic DNA and RNA synthesis. These moieties inhibit DNA and RNA synthesis, in a dose-dependent fashion, when added in vitro to nuclei isolated from the liver of male or female rats. The inhibition is due to a decrease of the initial rate of synthesis and of the total amount of labeled precursor incorporated into the growing chains. When administered in vivo both the oncogenic ZAMI 1305 and its non-oncogenic isomer ZAMI 1327 inhibit hepatic DNA and RNA synthesis in female rats, as evaluated by the determination of nucleic acids synthesis in liver nuclei isolated from female rats 5 and 15 min after the injection of the drug. No influence on hepatic DNA and RNA synthesis is observed when the molecules are administered to male rats. The in vivo administration of DL-propranolol causes an increase of hepatic DNA and RNA synthesis in male rats, while it is uneffective in female rats.
References
1.
1. Adams MP and Goodman JI (1976). RNA synthesis and RNA polymerase activity in hepatic nuclei isolated from rats fed the carcinogen 2-acetylaminofluorene.Biochem. Biophys. Res. Commun.68: 850–856.
2.
2. Armitage P (1971). Statistical Methods in Medical Research, Blackwell Scientific Publications, London.
3.
3. Bitensky MW, Russel V, and Blanco M (1970). Independent variation of glucagon and epinephrine responsive components of hepatic adenyl cyclase as a function of age, sex and steroid hormones.Endocrinology86: 154–159.
4.
4. Blair JB, James ME, and Foster JL (1979). Adrenergic control of glucose output and adenosine 3′:5′-monophosphate levels in hepatocytes from juvenile and adult rats.J. Biol. Chem.254: 7579–7584.
5.
5. Boyd H and Martin TJ (1977). The effect of propranolol on induction of rat liver tumors by a chemical carcinogen.Mol. Pharmacol.13: 576–578.
6.
6. Burke JF, Duff PM, and Pearson CK (1979). Effect of drugs on deoxyribonucleic acid synthesis in isolated mammalian cell nuclei: comparison with partially purified deoxyribonucleic acid polymerases.Biochem. J.178: 621–626.
7.
7. Chan JYH and Becker FF (1981). Differential inhibition of rat liver DNA polymerases in vitro by direct-acting carcinogens and the protective effect of a thiol reducing agent.Biochem. J.193: 985–990.
8.
8. Faccini JM, Irisarri E, and Monro AM (1981). A carcinogenicity study in mice of a β-adrenergic antagonist, primidolol; increased total tumors incidence without tissue specificity.Toxicology21: 279–290.
9.
9. Food and Drug Administration (1978). Status report on β-blockers. FDA Drug Bull.8: 13.
10.
10. Glazer RI (1976). Alterations in the transcriptional capacity of hepatic DNA-dependent RNA polymerases I and II by N-hydroxy-2-acetylaminofluorene.Cancer. Res.36: 2282–2288.
11.
11. Grunberger D and Weinstein IB (1979). Biochemical effects of the modification of nucleic acids by certain polycyclic aromatic carcinogens.Prog. Nucleic Acid Res. Mol. Biol.23: 105–149.
12.
12. Guzzo GJ and Glazer RI (1976). Effects of N-acetoxy-2-acetylaminofluorene and N-methyl-N'-nitro-N-nitrosoguanidine on nuclear DNA synthesis in rat liver.Cancer Res.36: 1041–1048.
13.
13. Herzog J, Serroni A, Briesmeister BA, and Farber JL (1975). N-Hydroxy-2-acetylaminofluorene inhibition of rat liver RNA polymerases.Cancer Res.35: 2138–2144.
14.
14. Kato R and Onoda K (1970). Studies on the regulation of the activity of drug oxidation in rat liver microsomes by androgen and estrogen.Biochem. Pharmacol.19: 1649–1660.
15.
15. Kedinger C, Gniazdowski M, Mandel JL, Gissinger F, and Chambon P (1970). α-Amanitin: a specific inhibitor of one of two DNA-dependent RNA polymerase activities from calf thymus.Biochem. Biophys. Res. Commun.38: 165–171.
16.
16. Krall JF, Mori H, Tuck ML, Leshon SL, and Korenman SG (1978). Demonstration of adrenergic catecholamin receptors in rat myometrium and their regulation by sex steroid hormones.Life Sci.23: 1073–1082.
17.
17. Marquardt H, Frederick SP, and Bendich A (1972). DNA binding and inhibition of DNA synthesis after 7,12-dimethylbenz(a)anthracene administered during the early prereplicative phase in regenerating rat liver.Cancer Res.32: 1810–1813.
18.
18. Müller WEG, Maidhof A, Arendes J, Geurtsen W, Zahn RK, and Schmidseder R (1979). Additive effects of bleomycin and neocarzinostatin on degradation of DNA, inhibition of DNA polymerase β, and cell growth.Cancer Res.39: 3768–3773.
19.
19. Ong H, Du Souich P, and Marchand C (1981). In vivo study of propranolol and metabolite(s) disposition in rat liver.Drug Metab. Dispos.9: 529–534.
20.
20. Paget GE (1963). Carcinogenic action of pronethalol.Br. Med. J.16: 1266–1267.
21.
21. Porterfield JS (1960). A simple plaque-inhibition test for the study of arthropode-borne viruses.Bull. WHO22: 373–380.
22.
22. Presta M, Mazzocchi C, Ziliani S, and Ragnotti G (1983). In vitro inhibition of rat liver DNA polymerases α and β by β-blockers. Biosci. Rep.3: 299–308.
23.
23. Presta M, Mazzocchi C, Ziliani S, and Ragnotti G (1983). In vitro and in vivo DNA damage of male and female rat liver nuclei by oncogenic and non-oncogenic β-blockers.J. Natl. Cancer Inst.70: 747–752.
24.
24. Presta M, Riboni L, and Ragnotti G (1982). Inhibition in vitro of yeast DNA polymerase I activity by β-blockers.Biosci. Rep.2: 55–62.
25.
25. Ragnotti G, Presta M, Riboni L, and Zavanella T (1982). Liver tumors induced by a new β-adrenoreceptor blocking agent in female rats.J. Natl. Cancer Inst.68: 669–672.
26.
26. Sarngadharan MG, Guroff MR, and Gallo RC (1978). DNA polymerases of normal and neoplastic mammalian cells.Biochim. Biophys. Acta516: 419–487.
27.
27. Tanaka M and Yoshida S (1980). Mechanism of the inhibition of calf thymus DNA polymerases α and β by daunomycin and adriamycin.J. Biochem.87: 911–918.
28.
28. Tolbert MEM, Butcher FR, and Fain JN (1973). Lack of correlation between catecholamine effects on cyclic adenosine 3′:5′-monophosphate and gluconeogenesis in isolated rat liver cells.J. Biol. Chem.248: 5686–5692.
29.
29. Troll W, Belman S, Berkowitz E, Chmielewicz ZF, Andrus JL, and Bardos TJ (1968). Differential responses of DNA and RNA polymerases to modifications of the template rat liver DNA caused by action of the carcinogen acetyl-aminofluorene in vivo and in vitro.Biochim. Biophys. Acta157: 16–24.
30.
30. Tutton PJM and Steel GG (1979). Influence of biogenic amines on the growth of xenografted human colorectal carcinomas.Br. J. Cancer40: 743–749.
31.
31. Voets R, Lagrou A, Hilderson H, Van Dessel G, and Dierick W (1979). RNA synthesis in isolated bovine thyroid nuclei and nucleoli: α-amanitin effect, a hint to the existence of a specific regulatory system.Hoppe-Seylers Z. Physiol. Chem.360: 1271–1283.
32.
32. Wagner HR, Crutcher KA, and Davis JN (1979). Chronic estrogen treatment decreases β-adrenergic responses in rat cerebral cortex.Brain Res.171: 147–151.
33.
33. Wick MM (1980). Levodopa and dopamine analogs as DNA polymerase inhibitors and antitumor agents in human melanoma.Cancer Res.40: 1414–1418.
